CCEL
Cryo-Cell International, Inc.
3.29
300 x 3.15
100 x 3.76
bid
ask
+
0.01
0.30%
09:47 AM
timesize
| Ytd | -4.36% | |
| 1y | -35.49% |
3.27
day range
3.47
2.72
52 week range
5.43
| Open | 3.47 | Prev Close | 3.28 | Low | 3.27 | High | 3.47 | Mkt Cap | 26.50M |
| Vol | 2.01K | Avg Vol | 8.56K | EPS | -0.32 | P/E | N/A | Forward P/E | 96.63 |
| Beta | 0.51 | Short Ratio | 0.51 | Inst. Own | 11.18% | Dividend | 1.00 | Div Yield | 12.77 |
| Ex Div Date | 11-15 | Earning | 07-18 | 50-d Avg | 3.54 | 200-d Avg | 3.74 | 1yr Est | 9.00 |
| Income Statement | |||
| Total Revenue | 7.68M | ||
| Revenues (USD) | 7.68M | ||
| Cost of Revenue | 1.66M | ||
| Gross Profit | 6.03M | ||
| Operating Expenses | 5.26M | ||
| Research and Development Expense | 65.76K | ||
| Selling, General and Administrative Expense | 5.01M | ||
| Operating Income | 765.13K | ||
| Interest Expense | 462.71K | ||
| Income Tax Expense | 23.20K | ||
| Net Income | 47.11K | ||
| Net Income Common Stock | 47.11K | ||
| Net Income Common Stock (USD) | 47.11K | ||
| Consolidated Income | 47.11K | ||
| Earnings per Basic Share | 0.01 | ||
| Earnings per Basic Share (USD) | 0.01 | ||
| Earnings per Diluted Share | 0.01 | ||
| Earning Before Interest & Taxes (EBIT) | 533.02K | ||
| Earning Before Interest & Taxes (USD) | 533.02K | ||
| Weighted Average Shares | 8.06M | ||
| Weighted Average Shares Diluted | 8.06M | ||
| Balance Sheet | |||
| Cash and Equivalents | 249.67K | ||
| Cash and Equivalents (USD) | 249.67K | ||
| Investments | 2.65M | ||
| Investments Current | 2.65M | ||
| Trade and Non-Trade Receivables | 6.82M | ||
| Current Assets | 11.08M | ||
| Property, Plant & Equipment Net | 21.59M | ||
| Total Assets | 60.88M | ||
| Debt Current | 2.22M | ||
| Total Debt | 10.71M | ||
| Current Liabilities | 17.76M | ||
| Debt Non-Current | 8.50M | ||
| Total Liabilities | 79.29M | ||
| Accumulated Retained Earnings (Deficit) | -38.39M | ||
| Shareholders Equity | -18.40M | ||
| Shareholders Equity (USD) | -18.40M | ||
| Assets Non-Current | 49.81M | ||
| Total Debt (USD) | 10.71M | ||
| Deferred Revenue | 61.46M | ||
| Goodwill and Intangible Assets | 2.79M | ||
| Inventory | 1.13M | ||
| Liabilities Non-Current | 61.52M | ||
| Trade and Non-Trade Payables | 3.30M | ||
| Tax Assets | 23.62M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 342.00K | ||
| Net Cash Flow from Financing | -740.29K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -69.36K | ||
| Capital Expenditure | -67.06K | ||
| Issuance (Repayment) of Debt Securities | -740.29K | ||
| Net Cash Flow from Investing | 19.10K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 86.17K | ||
| Net Cash Flow from Operations | 651.83K | ||
| Share Based Compensation | 158.55K | ||